Richard J Aspinall

7PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Respiratory diseasesClinical pharmacology and therapeuticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid.

Sarah Dunn, Lysbeth Evans, Ciara Kennedy

|Feb 11, 2025
Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK.

Helen Crisp, Oliver Tavabie, Yvanne Enever

|Mar 22, 2024
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).

Dhiraj Tripathi, David Patch, Homoyon Mehrzad

|Mar 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosis.

Benjamin Giles, Kirsty Fancey, Karen Gamble

|Oct 31, 2023
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.

Marlyn J Mayo, John M Vierling, Christopher L Bowlus

|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein

Pageof 2

Frequent Collaborators

3 joint publications

Palak Trivedi

2 joint publications

Adrian Stanley

2 joint publications

Christopher L Bowlus

2 joint publications

John M Vierling